Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
批准号:
8736589
负责人:
David Schlessinger
金额:
$55.08万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAgeAge-YearsAgingAllelesAutoimmune DiseasesBaltimoreBibliographyBiochemicalBlood PressureBlood TestsBone DensityCD4 Positive T LymphocytesCardiovascular DiseasesCardiovascular systemCatalogingCatalogsCell MaturationCellsCholesterolClinicalCohort StudiesDNADNA SequenceDendritic CellsDiseaseEarly DiagnosisEchocardiographyEnvironmentEnvironmental Risk FactorEpidemiological FactorsEventFamilyGenesGeneticGenetic VariationGenomeGenome ScanGenotypeGoalsHematopoiesisHourHumanImmuneImmune systemIncidenceIndividualInheritedInsulin-Dependent Diabetes MellitusInterventionLeukocytesLifeLongitudinal StudiesLymphocyteMeasurementMeasuresMolecular TargetMultiple SclerosisNucleotidesObesityOutcomeOverweightPatientsPersonalityPhenotypePopulationPopulation StudyPublicationsRecording of previous eventsRegulationRegulatory T-LymphocyteRiskRisk FactorsRouteSamplingSardiniaSeriesSeverity of illnessSickle Cell AnemiaSorting - Cell MovementStagingT-LymphocyteTestingThalassemiaTimeTo specifyVariantVisitWeightY Chromosomeage relatedblood lipidcardiovascular risk factorcell typecellular targetingcohortdesigndisorder riskendophenotypeexomefrailtygenetic analysisgenome wide association studyinterestloss of functionmalignant breast neoplasmmonocytetraittrend
中文摘要
撒丁岛研究人口队列包括来自撒丁岛四个城镇的7 000多名研究对象,年龄从14-102岁不等。该研究测量了bbb300个定量性状(内表型或定量风险相关的遗传或环境因素),这些性状可以连续评分,并被设计为纵向研究,在其任期的前13年进行了4次访问。特别感兴趣的特征包括一系列心血管危险因素、人体测量值、血液测试值和个性方面。目前正在对研究队列进行第四次访问,以评估纵向趋势和结果,以及评估与骨密度和脆弱作为年龄函数相关的其他表型。例如,24小时血压测量和超声心动图扩展了对心血管特征的分析;这个队列被特别扩展到超过250个92岁以上的人来分析极端年龄的影响。
英文摘要
The SardiNIA study population cohort comprises over 7,000 subjects, starting at ages from 14-102, from a cluster of four towns in Sardinia. The study has been measuring >300 quantitative traits (endophenotypes or quantitative risk-related genetic or environmental factors) that can be scored on a continuous scale, and is designed as a longitudinal studies, with 4 visits over the first 13 years of its tenure. Traits of special interest include a range of cardiovascular risk factors, anthropometric measurements, blood test values, and facets of personality. Fourth visits are now in progress for the study cohort to permit the assessment of longitudinal trends and outcomes, as well as the assessment of additional phenotypes related to bone density and frailty as a function of age. For example, 24 hour blood pressure measurements and ECHOcardiography are extending the analysis of cardiovascular traits; and the cohort is being specifically extended to over 250 individuals over 92 years of age to analyze effects of extreme age.
With this cohort, full-genome scans with batteries of single-nucleotide markers were conducted, and were supplemented in the last year with full genome DNA sequencing and genotyping with specialized chips (metabochip, immunochip, and exome chip, and a chip designed to give equal coverage across the entire genome). These have provided a catalogue of over 17,000,000 variants, including a range of relatively rare variants, which are being tested for association with traits and diseases in Genome-wide association scans (GWAS). In addition, 1,000 individuals have provided lymphocyte samples for analysis (see below).
In studies thus far, GWAS have pointed to genes/variants that determine a significant portion of the genetic contribution to variance for each trait and disease studied. In conjunction with consortium efforts on other population cohorts, including the Baltimore Longitudinal Study of Aging and the InCHIANTI study supported by the NIA, an increasing number of publications have resulted that identify genes associated with obesity, cardiovascular traits, and levels of lipids and blood components. In particular, genes associated with HbF levels as a modulator of thalassemia/sickle cell disease severity have been identified, as well as findings of genetic factors determining loci for blood pressure, many affecting adiposity; and personality facets affecting under- and over-weight (see bibliography for a complete list). Supporting the range and depth of results are 3 of the most recent publications: in one, human demographic history was reconstructed from DNA sequences of 1,204 Y chromosomes in the cohort; a second inferred DNA variants that control up to 80% of the variability of at least one of 95 separated immune cell types; and a third identified a genetic locus that is associated with part of hereditary capacity for educational attainment.
In an additional new initiative in the past year, separation of 95 types of immune system cells was done for 3,400 individuals by flow-sorting to determine levels of general leukocyte sub-populations (B and T, natural killer, monocytes, etc.) and subclasses of T-regulatory cells, dendritic cells, and T cell maturation stages; the variation of levels of many cell types especially Tregs is up to 87% genetically determined; and GWAS analysis on 1,200 individuals with the 12,500,000 SNP set then revealed 23 with a large effect on at least one cell type. For example, the R262W SH2B3 variant, already associated with several autoimmune diseases and negative regulation of hematopoiesis, was shown to particularly affect the numbers of CD4+ T cells, likely resulting in a loss of function.
In a complementary approach, cohorts of Sardinian patients and controls were assembled and genotyped for GWAS for each of several diseases, Type 1 diabetes, multiple sclerosis (MS), and breast cancer. GWAS with approximately 6.6 million SNPs in over 3,000 patients and 3,500 controls identified CBLB as associated with MS. CBLB involvement in MS was technically easier to find in Sardinia, but has now been widely replicated in other patient cohorts.
Our analyses extend associations of variants with a disease to specify the cell types in which the alleles have their effects. This provides a further step in supplying markers and potential molecular and cellular targets for possible eventual intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glypican 3 Action In Overgrowth Syndromes
-
批准号:6508426
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:7592038
-
项目类别:
-
资助金额:$33.1万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development /Applications Of Open Microscopy Environment
-
批准号:6668443
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Role Of Ectodysplasin-a In Skin Appendage Formation
-
批准号:8736579
-
项目类别:
-
资助金额:$68.85万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Role of Hyperplasia Suppressor Gene (HSG) in cell growth.
-
批准号:9147302
-
项目类别:
-
资助金额:$38.94万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:8335890
-
项目类别:
-
资助金额:$37.49万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Role Of Ectodysplasin-a In Skin Appendage Formation
-
批准号:7732268
-
项目类别:
-
资助金额:$41.62万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Developmental Genes in Sebaceous Glands and Keratinocytes
-
批准号:7732282
-
项目类别:
-
资助金额:$33.02万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Systematic analysis of gene regulatory networks
-
批准号:9341859
-
项目类别:
-
资助金额:$16.51万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Spatial Mapping Of Gene Expression Early Mouse Embryo
-
批准号:7132311
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Systematic analysis of gene regulatory networks
-
批准号:8736583
-
项目类别:
-
资助金额:$56.59万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Expression profiling of mouse embryonic and tissue stem cells
-
批准号:8552434
-
项目类别:
-
资助金额:$84.23万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development and maintenance of bioinformatics tools for mouse biology
-
批准号:8552444
-
项目类别:
-
资助金额:$89.77万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Genes Associated With Ovarian Development and Premature Ovarian Failure
-
批准号:9147313
-
项目类别:
-
资助金额:$71.63万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
-
批准号:9549327
-
项目类别:
-
资助金额:$95.22万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development and maintenance of bioinformatics tools for mouse biology
-
批准号:8931569
-
项目类别:
-
资助金额:$69.98万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Development And Applications Of The Open Microscopy Envi
-
批准号:7326108
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Heritability and Covariate Traits in Sardinian and Other
-
批准号:7326499
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Genes Associated With Ovarian Development and Premature Ovarian Failure - test
-
批准号:9341858
-
项目类别:
-
资助金额:$66.62万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
Glypican 3 Action in Overgrowth Syndromes
-
批准号:6097861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David Schlessinger
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: